Christopher R. Cabanski

Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes

Vonn Walter, Xiaoying Yin, Matthew D. Wilkerson et al. · PLoS ONE · 2013 · 330 citations · Full text

Engineering, Genetics, Canonical Cancer Genes +22

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 316 citations · Full text

Randomized Phase 2, Pancreatic Cancer, Gastrointestinal Oncology +13

Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation

Matthew D. Wilkerson, Xiaoying Yin, Vonn Walter et al. · PLoS ONE · 2012 · 295 citations · Full text

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types

Matthew D. Wilkerson, Xiaoying Yin, Katherine A. Hoadley et al. · Clinical Cancer Research · 2010 · 290 citations · Full text

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary et al. · The Lancet Oncology · 2020 · 286 citations

Phase 1B, Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma +7